News Sentiment

MRVI sentiment intelligence

Maravai Lifesciences Holdings Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 62 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 6.09 Week of 10 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

76/100 classification confidence.

Company focus 54

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend active

+0.8% over one week, +22.3% over four weeks, trend active, and near fair-value range.

Latest direct headline Neutral

Maravai LifeSciences(MRVI) Stock Options Chain | Quotes & News

Market Reaction

Balanced read

48/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 76/100 classification
One-week reaction 0.8% Price digesting
Trend fit Trend active 22.3% over four weeks
Fair value 9.8% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 8
Neutral 51
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 54
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 23
Market source 10
TradingView 6
MT Newswires 4
simplywall.st 4
Seeking Alpha 2
Moomoo 1
Investing.com Nigeria 1

Event Lens

What the news is about

Classified themes
Market update 28
Earnings 20
Deals and strategy 7
Balance sheet 4
Analyst action 2
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 62
Stock Titan Direct company coverage

Maravai Lifesciences (MRVI) CEO reports 29,250-share tax withholding event

Maravai Lifesciences (MRVI) CEO Bernd Brust reported the withholding of 29,250 Class A shares to cover tax obligations related to the vesting of restricted stock units. This was a non-open-market, tax-related disposition, not a sale. After this transaction, Brust directly holds 1

Tone
Neutral 50/100
Event
Market update
Published
10 Jul 2026 21:10
Source
Stock Titan
Stock Titan Direct company coverage

Maravai (MRVI) CFO has 65,584 shares withheld for RSU tax

Maravai Lifesciences Holdings CFO Rajesh Asarpota reported a routine disposition of 65,584 Class A Common Stock shares. These shares were withheld at $6.39 each to cover tax obligations upon the vesting of restricted stock unit awards. As a result, Asarpota now directly holds 434

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 01:10
Source
Stock Titan
TradingView Direct company coverage

ETFs Investing in Maravai Lifesciences Holdings, Inc. Class A Stocks

This article provides a list of Exchange Traded Funds (ETFs) that hold Maravai Lifesciences Holdings, Inc. Class A stocks, sorted by market value. It details various ETFs including their market value, weight, issuer, management style, focus, expense ratio, AUM, price change, rela

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 02:39
Source
TradingView
Stock Titan Direct company coverage

Millennium Management reports >5% stake then falls below 5% in MRVI (MRVI)

Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander reported acquiring over a 5% beneficial ownership stake in Maravai LifeSciences Holdings, Inc. (MRVI) on June 23, 2026, via a Schedule 13G filing. However, by the filing date, they had ceased to b

Tone
Neutral 50/100
Event
Deals and strategy
Published
30 Jun 2026 02:36
Source
Stock Titan
TradingView Direct company coverage

Price to earnings forward of Maravai Lifesciences Holdings, Inc. Class A – SWB:MAR

This page displays the "Price to earnings forward" metric for Maravai Lifesciences Holdings, Inc. Class A, traded on the Stuttgart Stock Exchange under the symbol MAR. The primary content consists of various navigation links and footer information from the TradingView platform, w

Tone
Neutral 50/100
Event
Earnings
Published
29 Jun 2026 03:12
Source
TradingView
TradingView Direct company coverage

MAR Forecast — Price Target — Prediction for 2027

This article provides a forecast and price target for Maravai Lifesciences Holdings, Inc. (MAR) stock for 2027, based on analyst opinions. It details the company's financial performance, including recent earnings and revenue, and addresses frequently asked questions about its sto

Tone
Neutral 50/100
Event
Earnings
Published
27 Jun 2026 00:09
Source
TradingView
TradingView Direct company coverage

Maravai Lifesciences Holdings, Inc. Class A Actuals & Estimates (NASDAQ:MRVI)

This article provides key financial metrics and analyst forecasts for Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI). It details the company's stock performance, market capitalization, earnings, revenue, and other financial data, highlighting recent fluctuations and future es

Tone
Positive 72/100
Event
Earnings
Published
26 Jun 2026 00:39
Source
TradingView
Stock Titan Direct company coverage

Millennium (MRVI) reports 7.32M shared stake, 4.96% as of Jun 16, 2026

Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander filed a Schedule 13G for Maravai LifeSciences Holdings, Inc. (MRVI). The filing indicates shared beneficial ownership of 7,323,520 Class A common shares, representing 4.96% as of June 16, 2026. Al

Tone
Neutral 50/100
Event
Deals and strategy
Published
23 Jun 2026 22:52
Source
Stock Titan
Investing.com Direct company coverage

Maravai LifeSciences general counsel Oreshack sells $253,999 shares

Kurt Oreshack, General Counsel at Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI), recently sold 50,000 shares of the company's Class A Common Stock for approximately $253,999. These sales were conducted under a Rule 10b5-1 trading plan and occurred on June 9 and 10, 2026, with

Tone
Neutral 50/100
Event
Market update
Published
11 Jun 2026 00:10
Source
Investing.com
Stock Titan Direct company coverage

Maravai Lifesciences director gifts 92,586 shares | MRVI Insider Trading

Maravai Lifesciences Holdings director Gregory T. Lucier reported gifting 92,586 shares of Class A common stock on June 9, 2026. The gifts were made in two bona fide transfers of 46,293 shares each at $0.00 per share. Following these transactions, Lucier directly holds 155,123 sh

Tone
Neutral 50/100
Event
Market update
Published
10 Jun 2026 21:10
Source
Stock Titan
Stock Titan Direct company coverage

Maravai (NASDAQ: MRVI) General Counsel sells 50,000 shares under 10b5-1 plan

Maravai Lifesciences' General Counsel, Kurt Oreshack, sold a total of 50,000 shares of Class A Common Stock through open-market transactions on June 9 and June 10, 2026. These sales, totaling $254,000, were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 1

Tone
Negative 28/100
Event
Market update
Published
10 Jun 2026 21:10
Source
Stock Titan
Stock Titan Direct company coverage

MRVI SEC Filings - Maravai Lifesciences Holdings, Inc. 10-K, 10-Q, 8-K Forms

This page provides a comprehensive resource for Maravai Lifesciences Holdings (MRVI) SEC filings, including annual reports (10-K), quarterly reports (10-Q), material event filings (8-K), and insider trading forms. Recent filings detail director equity awards, a CFO transition, an

Tone
Neutral 50/100
Event
Market update
Published
10 Jun 2026 21:10
Source
Stock Titan
Stock Titan Direct company coverage

Kurt Oreshack notifies sale of 25,000 MRVI Class A shares (NASDAQ: MRVI)

Kurt Oreshack has filed a Form 144 to sell 25,000 Class A shares of Maravai Lifesciences Holdings, Inc. (MRVI). The filing, dated June 10, 2026, indicates an aggregate amount of $127,500.00 and notes that the securities originated from Restricted Stock Vesting on January 15, 2025

Tone
Neutral 50/100
Event
Market update
Published
10 Jun 2026 19:39
Source
Stock Titan
Stock Titan Direct company coverage

Maravai (MRVI) brokered sale notice: 25,000 Class A shares via Fidelity

Maravai LifeSciences (MRVI) has filed a Form 144, indicating an intent to sell 25,000 Class A common shares through Fidelity Brokerage Services LLC on NASDAQ. The filing details previous acquisitions of these shares through restricted stock vesting and ESPP purchases. This is a r

Tone
Neutral 50/100
Event
Deals and strategy
Published
09 Jun 2026 14:39
Source
Stock Titan
Stock Titan Direct company coverage

Maravai LifeSciences (MRVI) shareholders approve directors, auditor and pay at 2026 meeting

Maravai LifeSciences Holdings, Inc. announced the results of its 2026 Annual Meeting of Shareholders. During the meeting, shareholders elected three directors to three-year terms, ratified Deloitte & Touche LLP as the independent registered public accounting firm for 2026, and ap

Tone
Neutral 50/100
Event
Earnings
Published
29 May 2026 20:39
Source
Stock Titan
Stock Titan Direct company coverage

Maravai (MRVI) director granted 46,293 restricted stock units

Maravai LifeSciences Holdings director Gregory T. Lucier was granted 46,293 restricted stock units of Class A Common Stock on May 26, 2026, with a grant price of $0.00. This award, under the 2020 Omnibus Incentive Plan, vests in full on the earlier of one year from the grant date

Tone
Neutral 50/100
Event
Market update
Published
29 May 2026 00:39
Source
Stock Titan
Stock Titan Direct company coverage

Maravai (MRVI) director Susannah Gray receives 46,293-share stock unit award

Maravai LifeSciences Holdings, Inc. director Susannah Gray was granted 46,293 restricted stock units (RSUs) of Class A Common Stock. This award, made under the 2020 Omnibus Incentive Plan, increased her direct holdings to 216,200 shares. The RSUs will vest in full after one year

Tone
Neutral 50/100
Event
Market update
Published
28 May 2026 22:10
Source
Stock Titan
Stock Titan Direct company coverage

[Form 4] MARAVAI LIFESCIENCES HOLDINGS, INC. Insider Trading Activity

Maravai LifeSciences (MRVI) director Gregory T. Lucier reported an acquisition of 46,293 shares of Class A Common Stock through restricted stock units (RSUs) at a reference price of $4.38 per share. This RSU award, granted under the 2020 Omnibus Incentive Plan, vests fully on the

Tone
Neutral 50/100
Event
Deals and strategy
Published
28 May 2026 22:10
Source
Stock Titan